{"title":"反流性食管炎。","authors":"Kyoungwon Jung","doi":"10.7704/kjhugr.2025.0001","DOIUrl":null,"url":null,"abstract":"<p><p>Reflux esophagitis is a significant clinical manifestation of gastroesophageal reflux disease (GERD), and its prevalence is increasing because of lifestyle changes and increasing obesity. The diagnosis of GERD primarily emphasizes symptom-based approaches that focus on heartburn and acid regurgitation. GERD can be confirmed through proton pump inhibitor (PPI) therapy, endoscopy, and 24-hour impedance-pH monitoring. Of these methods, endoscopy plays a critical role in diagnosing reflux esophagitis. Recently, both PPIs and potassium-competitive acid blockers (P-CABs) have been recommended as first-line treatments, with P-CABs showing greater efficacy in severe cases or in patients unresponsive to PPIs. This review discusses the prevalence and risk factors of reflux esophagitis, presents the latest insights into its pathophysiology and diagnosis, and provides a comparative analysis of recent domestic and international guidelines.</p>","PeriodicalId":520887,"journal":{"name":"The Korean journal of helicobacter and upper gastrointestinal research","volume":"25 2","pages":"98-107"},"PeriodicalIF":0.0000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12173581/pdf/","citationCount":"0","resultStr":"{\"title\":\"Reflux Esophagitis.\",\"authors\":\"Kyoungwon Jung\",\"doi\":\"10.7704/kjhugr.2025.0001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Reflux esophagitis is a significant clinical manifestation of gastroesophageal reflux disease (GERD), and its prevalence is increasing because of lifestyle changes and increasing obesity. The diagnosis of GERD primarily emphasizes symptom-based approaches that focus on heartburn and acid regurgitation. GERD can be confirmed through proton pump inhibitor (PPI) therapy, endoscopy, and 24-hour impedance-pH monitoring. Of these methods, endoscopy plays a critical role in diagnosing reflux esophagitis. Recently, both PPIs and potassium-competitive acid blockers (P-CABs) have been recommended as first-line treatments, with P-CABs showing greater efficacy in severe cases or in patients unresponsive to PPIs. This review discusses the prevalence and risk factors of reflux esophagitis, presents the latest insights into its pathophysiology and diagnosis, and provides a comparative analysis of recent domestic and international guidelines.</p>\",\"PeriodicalId\":520887,\"journal\":{\"name\":\"The Korean journal of helicobacter and upper gastrointestinal research\",\"volume\":\"25 2\",\"pages\":\"98-107\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12173581/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Korean journal of helicobacter and upper gastrointestinal research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.7704/kjhugr.2025.0001\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/6/4 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Korean journal of helicobacter and upper gastrointestinal research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7704/kjhugr.2025.0001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/4 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
Reflux esophagitis is a significant clinical manifestation of gastroesophageal reflux disease (GERD), and its prevalence is increasing because of lifestyle changes and increasing obesity. The diagnosis of GERD primarily emphasizes symptom-based approaches that focus on heartburn and acid regurgitation. GERD can be confirmed through proton pump inhibitor (PPI) therapy, endoscopy, and 24-hour impedance-pH monitoring. Of these methods, endoscopy plays a critical role in diagnosing reflux esophagitis. Recently, both PPIs and potassium-competitive acid blockers (P-CABs) have been recommended as first-line treatments, with P-CABs showing greater efficacy in severe cases or in patients unresponsive to PPIs. This review discusses the prevalence and risk factors of reflux esophagitis, presents the latest insights into its pathophysiology and diagnosis, and provides a comparative analysis of recent domestic and international guidelines.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
